Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 26, 2021
Share
Guangxi Liuzhou Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was CNY 4,161.500 million compared to CNY 3,615.522 million a year ago. Operating income was CNY 263.480 million compared to CNY 232.510 million a year ago. Net income was CNY 207.750 million compared to CNY 185.008 million a year ago. Basic earnings per share from continuing operations was CNY 0.57 compared to CNY 0.51 a year ago.
Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and research and development of pharmaceuticals and medical devices. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services, etc.
GUANGXI LIUYAO GROUP CO., LTD 
